(Q35053462)

6 August 2017

1 reference

title

Influenza virosomes: combining optimal presentation of hemagglutinin with immunopotentiating activity (English)

1 reference

6 August 2017

5

Toos Daemen

1 reference

6 August 2017

7

Jan Wilschut

1 reference

6 August 2017

1

Anke Huckriede

1 reference

6 August 2017

Laura Bungener

2

1 reference

6 August 2017

Wouter ter Veer

series ordinal

3

1 reference

6 August 2017

Marijke Holtrop

series ordinal

4

1 reference

6 August 2017

Abraham M Palache

series ordinal

6

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

21

1 reference

6 August 2017

issue

9-10

1 reference

6 August 2017

page(s)

925-931

1 reference

Economic evaluation of influenza vaccination. Assessment for The Netherlands

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

1 reference

7 January 2021

Comparison of Serology and Reactogenicity between Influenza Subunit Vaccines and Whole Virus or Split Vaccines: A Review and Meta-Analysis of the Literature

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

Influenza vaccines. A reappraisal of their use.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-centre, dose-response study in elderly nursing-home residents and young volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

A two-phase model of B-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

Subunit vaccines against enveloped viruses: virosomes, micelles and other protein complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

The influence of virus structure on antibody responses and virus serotype formation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

Neutralizing antiviral B cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

The influence of antigen organization on B cell responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

T-Cell-independent immunoglobulin G responses in vivo are elicited by live-virus infection but not by immunization with viral proteins or virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

Molecular determinants of immunogenicity: the immunon model of immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

Regulation of the immune response by antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

Cross-linked protein crystals for vaccine delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

Phagocytic antigen processing and effects of microbial products on antigen processing and T-cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

Influenza vaccines: new developments.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

Development of non-live vectors and procedures (liposomes, pseudo-viral particles, toxin, beads, adjuvantsellipsis) as tools for cancer vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

Fusogenic liposomes efficiently deliver exogenous antigen through the cytoplasm into the MHC class I processing pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

Induction of cytotoxic T lymphocyte activity by fusion-active peptide-containing virosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

Dendritic cells: specialized and regulated antigen processing machines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

Maturation, activation, and protection of dendritic cells induced by double-stranded RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

Cold-attenuated live influenza vaccines, a risk-benefit assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

Formation of virosomes from influenza subunits and liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

Preparation, properties, and applications of reconstituted influenza virus envelopes (virosomes).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

Influenza virosomes in vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

Infectious entry pathway of influenza virus in a canine kidney cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

Immunogenicity of new virosome influenza vaccine in elderly people

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

Immunopotentiation of local and systemic humoral immune responses by ISCOMs, liposomes and FCA: role in protection against influenza A in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. I. Vaccine characterization and efficacy studies in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

Design, characterization and preclinical efficacy of a cationic lipid adjuvant for influenza split vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

Whole virus influenza vaccine activates dendritic cells (DC) and stimulates cytokine production by peripheral blood mononuclear cells (PBMC) while subunit vaccines support T cell proliferation.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

Virosome-mediated delivery of protein antigens to dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

Immunogenicity of trivalent subunit versus virosome-formulated influenza vaccines in geriatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

Comparison of immunogenicity and safety of a virosome influenza vaccine with those of a subunit influenza vaccine in pediatric patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

Cellular cytoplasmic delivery of a polypeptide toxin by reconstituted influenza virus envelopes (virosomes).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900542-X

7 January 2021

10.1016/S0264-410X(02)00542-X

Identifiers

DOI

1 reference

6 August 2017

1 reference